metricas
covid
Buscar en
Clinics
Toda la web
Inicio Clinics Association between matrix metalloproteinase-9 gene polymorphism and breast canc...
Journal Information

Statistics

Follow this link to access the full text of the article

ORIGINAL ARTICLE
Association between matrix metalloproteinase-9 gene polymorphism and breast cancer in Brazilian women
Victor Alves de OliveiraI,
Corresponding author
, Diego Cipriano ChagasI, Jefferson Rodrigues AmorimI, Renato de Oliveira PereiraI, Thais Alves NogueiraI, Victória Maria Luz BorgesI, Larysse Maira Campos-VerdeII, Luana Mota MartinsI, Gilmara Peres RodriguesII, Elmo de Jesus Nery JúniorII, Fabiane Araújo SampaioII, Pedro Vitor Lopes-CostaI, João Marcelo de Castro e SousaI,II, Vladmir Costa SilvaII, Felipe Cavalcanti Carneiro da SilvaII, Benedito Borges da SilvaI,II
I Programa de Pos-Graduacao em Ciencias e Saude, Universidade Federal do Piaui, PI, BR
II Programa de Doutorado em Biotecnologia — Rede Nordeste de Biotecnologia (RENORBIO), Universidade Federal do Piaui, PI, BR
Read
1008
Times
was read the article
369
Total PDF
639
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 37 25 62
2024 October 48 28 76
2024 September 25 18 43
2024 August 38 29 67
2024 July 18 21 39
2024 June 17 11 28
2024 May 23 8 31
2024 April 38 17 55
2024 March 26 15 41
2024 February 21 17 38
2024 January 8 13 21
2023 December 13 16 29
2023 November 21 28 49
2023 October 23 27 50
2023 September 24 27 51
2023 August 23 3 26
2023 July 11 18 29
2023 June 32 17 49
2023 May 51 5 56
2023 April 48 7 55
2023 March 35 6 41
2023 February 31 10 41
2023 January 16 0 16
2022 December 8 1 9
2022 November 4 2 6
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos